A phase II study of S-1 plus irinotecan and oxaliplatin in heavily-treated patients with metastatic colorectal cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A phase II study of S-1 plus irinotecan and oxaliplatin in heavily-treated patients with metastatic colorectal cancer

Published:2008-09-25 Issue:3 Volume:27 Page:269-274
ISSN:0167-6997
Container-title:Investigational New Drugs
language:en
Short-container-title:Invest New Drugs

Author:

Kim Sun Young,Hong Yong Sang,Kim Byung Chang,Park Ji Won,Choi Hyo Seong,Jeong Seung-Yong,Kim Dae Yong,Hong Chang Won,Sohn Dae Kyung,Jung Kyung Hae

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s10637-008-9177-5.pdf

Reference24 articles.

1. Meyerhardt JA, Mayer RJ (2005) Systemic therapy for colorectal cancer. N Engl J Med 352:476–487 doi: 10.1056/NEJMra040958

2. Azrak RG, Cao S, Slocum HK et al (2004) Therapeutic synergy between irinotecan and 5-fluorouracil against human tumor xenografts. Clin Cancer Res 10:1121–1129 doi: 10.1158/1078-0432.CCR-0913-3

3. Barone C, Landriscina M, Quirino M et al (2007) Schedule-dependent activity of 5-fluorouracil and irinotecan combination in the treatment of human colorectal cancer: in vitro evidence and a phase I dose-escalating clinical trial. Br J Cancer 96:21–28 doi: 10.1038/sj.bjc.6603496

4. Raymond E, Faivre S, Chaney S et al (2002) Cellular and molecular pharmacology of oxaliplatin. Mol Cancer Ther 1:227–235

5. Yeh KH, Cheng AL, Wan JP et al (2004) Down-regulation of thymidylate synthase expression and its steady-state mRNA by oxaliplatin in colon cancer cells. Anticancer Drugs 15:371–376 doi: 10.1097/00001813-200404000-00010

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Feasibility and Efficacy of Neoadjuvant Chemotherapy without Radiotherapy for Locally Advanced Rectal Cancer;Journal of the Anus, Rectum and Colon;2022-01-28

2. Feasibility and Efficacy of Neoadjuvant Chemotherapy without Radiotherapy for Locally Advanced Rectal Cancer;J ANUS RECTUM COLON;2022

3. DNA damage repair: historical perspectives, mechanistic pathways and clinical translation for targeted cancer therapy;Signal Transduction and Targeted Therapy;2021-07-09

4. Phase I dose escalation study of sorafenib plus S-1 for advanced solid tumors;Scientific Reports;2021-03-01

5. A systematic review of salvage therapies in refractory metastatic colorectal cancer;International Journal of Colorectal Disease;2020-03-26

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3